Search - tctmd.com

Displaying 861 - 880 of 1464

Sort: Relevancy | Date

News Conference News TCT 2015

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

October 11, 2015

News Industry News

Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses

October 06, 2015

News Industry News

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

October 06, 2015

News Industry News

MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System

October 05, 2015

News Industry News

Neuravi Announces European Launch of Innovative Minimally Invasive Stroke Therapy

October 01, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

News Industry News

AtriCure Announces Launch of the cryoFORM™ Cryoablation Probe

September 30, 2015

News Industry News

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

September 25, 2015

News Daily News

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

L.A. McKeown

September 21, 2015

News Industry News

Early Patient Cases with Mitra-Spacer™ System presented at PCR London Valves 2015

September 21, 2015

News Daily News

Cerebral Embolization Greater When Valvuloplasty Not Done Before TAVR

Todd Neale

September 21, 2015

News Industry News

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

September 21, 2015

News Industry News

St. Jude Medical Gains CE Mark for 27mm & 29mm Portico TAVR Valves to Complete a Full Portfolio of Portico Sizing Options for Physicians Treating Patients with Aortic Stenosis

September 18, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Daily News

Latest Watchman Design Appears Safer, More User-Friendly

Yael L. Maxwell

September 16, 2015

News Daily News

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

Yael L. Maxwell

September 14, 2015

News Industry News

QT Vascular wins CE Mark for drug-coated balloon

September 10, 2015

News Conference News ESC 2015

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

Yael L. Maxwell

September 02, 2015

News Industry News

Medtronic Study Detects Gene Associated with Sudden Cardiac Death

August 31, 2015

News Conference News ESC 2015

FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP

Yael L. Maxwell

August 30, 2015

Advertisement

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System

Neuravi Announces European Launch of Innovative Minimally Invasive Stroke Therapy

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

AtriCure Announces Launch of the cryoFORM™ Cryoablation Probe

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

Early Patient Cases with Mitra-Spacer™ System presented at PCR London Valves 2015

Cerebral Embolization Greater When Valvuloplasty Not Done Before TAVR

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

St. Jude Medical Gains CE Mark for 27mm & 29mm Portico TAVR Valves to Complete a Full Portfolio of Portico Sizing Options for Physicians Treating Patients with Aortic Stenosis

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Latest Watchman Design Appears Safer, More User-Friendly

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

QT Vascular wins CE Mark for drug-coated balloon

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

Medtronic Study Detects Gene Associated with Sudden Cardiac Death

FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content